Affiliations: [a] Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden
| [b] Department of Clinical Sciences, Psychiatry, Umeå University, Umeå, Sweden
| [c] Departments of Radiation Sciences and Integrative Medical Biology, Umeå University, Umeå, Sweden
Correspondence:
[*]
Correspondence to: Anders Öhman, Department of Pharmacology and Clinical Neuroscience, Umeå University, SE - 901 85 Umeå, Sweden. Tel.: +46 (0) 70 5955136; Fax: +46 (0) 90 143107; E-mail: [email protected].
Note: [1] Present address: Department of Chemistry, Umeå University, Umeå, Sweden.
Abstract: There is a great need for diagnostic biomarkers of impending dementia. Metabolite markers in blood have been investigated in several studies, but inconclusive findings encourage further investigation, particularly in the pre-diagnostic phase. In the present study, the serum metabolomes of 110 dementia or pre-diagnostic dementia individuals and 201 healthy individuals matched for age, gender, and education were analyzed by nuclear magnetic resonance spectroscopy in combination with multivariate data analysis. 58 metabolites were quantified in each of the 311 samples. Individuals with dementia were discriminated from controls using a panel of seven metabolites, while the pre-diagnostic dementia subjects were distinguished from controls using a separate set of seven metabolites, where threonine was a common significant metabolite in both panels. Metabolite and pathway alterations specific for dementia and pre-diagnostic dementia were identified, in particular a disturbed threonine catabolism at the pre-diagnostic stage that extends to several threonine-linked pathways at the dementia stage.
